Klaus Fenchel
- Oncology top 10%
- Immunology top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Genetics top 10%
- Co-authors
- Wolfram C. M. DempkePeter UciechowskiLothar BergmannStephen DaleD. HoelzerP.S. MitrouEckhart WeidmannBernhard Jahn
- Topics
- Lung Cancer Treatments and Mutations (6 papers)Blood disorders and treatments (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)
- Cited by
- GeneticsImmunologyOncology
- Partner nations
- GermanyUnited KingdomAustria
In The Last Decade
Klaus Fenchel
29 papers receiving 828 citations
Peers
Comparison fields: 5 of 74
- Oncology 340
- Immunology 287
- Molecular Biology 258
- Pulmonary and Respiratory Medicine 164
- Genetics 154
Countries citing papers authored by Klaus Fenchel
This map shows the geographic impact of Klaus Fenchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Fenchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Fenchel more than expected).
Fields of papers citing papers by Klaus Fenchel
This network shows the impact of papers produced by Klaus Fenchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Fenchel. The network helps show where Klaus Fenchel may publish in the future.
Co-authorship network of co-authors of Klaus Fenchel
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Fenchel. A scholar is included among the top collaborators of Klaus Fenchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Fenchel. Klaus Fenchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 11 | |
| 4 | 20 | |
| 5 | 1 | |
| 6 | 55 | |
| 7 | 19 | |
| 8 | 64 | |
| 9 | 68 | |
| 10 | 11 | |
| 11 | 1 | |
| 12 | 4 | |
| 13 | 12 | |
| 14 | 24 | |
| 15 | 55 | |
| 16 | 8 | |
| 17 | 4 | |
| 18 | 78 | |
| 19 | 27 | |
| 20 | 11 |
About Klaus Fenchel
Klaus Fenchel is a scholar working on Oncology, Immunology and Hematology, having authored 31 papers that have together received 855 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Blood disorders and treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Genetics (154 citations), Immunology (287 citations) and Oncology (340 citations). Klaus Fenchel has collaborated with scholars based in Germany, United Kingdom and Austria. Frequent co-authors include Wolfram C. M. Dempke, Peter Uciechowski, Lothar Bergmann, Stephen Dale, D. Hoelzer, P.S. Mitrou, Eckhart Weidmann, Bernhard Jahn, Jürgen Brieger and Paris S. Mitrou. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.